Doxapram treatment for preterm infants with breathing issues
Official title: Doxapram Versus Placebo in Preterm Newborns: An International Double Blinded Multicenter Randomized Controlled Trial
Run by Erasmus Medical Center · NCT04430790 · Data updated 2026-11-12
This study is testing if doxapram can help preterm infants with breathing problems avoid serious complications and reduce the need for breathing machines.
Quick facts
| Phase | Phase 3 |
|---|---|
| Study type | Interventional |
| Ages | 23 Weeks to 29 Weeks |
| Sex | All |
| Enrollment | 396 (estimated) |
| Sponsor | Erasmus Medical Center Academic / other |
| Locations | 24 sites (Brussels, Avenaue Hippocrate 10 and 23 other locations) |
| Status | Recruiting |
| Started | June 15, 2020 |
| Main results expected | May 1, 2026 |
| Study ends | May 1, 2034 |
| Registry record updated | April 4, 2024 |
| Trial ID | NCT04430790 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are preterm infants born at less than 29 weeks gestational age who are admitted to a neonatal intensive care unit and require medical intervention for apnea.
✕Probably not a fit
Patients with major congenital malformations or chromosomal defects that compromise lung function or increase the risk of adverse outcomes may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial investigates the safety and effectiveness of doxapram, a respiratory stimulant, in reducing the risk of death and neurodevelopmental impairment in preterm infants suffering from apnea of prematurity. Conducted in multiple neonatal intensive care units across the Netherlands and Belgium, the study involves a multicenter, double-blinded, randomized, placebo-controlled design. Infants will be randomly assigned to receive either doxapram or a placebo, with treatment administered continuously until the patient's condition allows for discontinuation. The trial aims to provide insights into whether doxapram can prevent the need for invasive mechanical ventilation in these vulnerable patients.
Why it matters
Potential benefit: If successful, this treatment could significantly reduce the incidence of severe disability and improve survival rates in preterm infants with apnea of prematurity.
How similar studies have gone: Previous studies have shown promise in using respiratory stimulants like doxapram for treating apnea of prematurity, but this specific trial aims to provide more definitive evidence.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Admitted to the neonatal intensvie care unit (NICU) of one of the participating centres * Written informed consent of both parents or legal representatives * Gestational age at birth \< 29 weeks * Caffeine therapy, adequately dosed (see also under co-medication) * Optimal Non-invasively supported with nasal Continuous Positive Airway Pressure (CPAP) or ventilation ((S)NIPPV, NIV-NAVA, BIPAP/Duopap, SIPAP) * Apnea that require a medical intervention as judged by the attending physician Exclusion Criteria: * Previous use of open label doxapram * Use of theophylline (to replace doxapram) * Chromosomal defects (e.g. trisomy 13, 18, or 21) * Major congenital malformations that: compromise lung function (e.g. surfactant protein deficiencies, congenital diaphragmatic hernia); result in chronic ventilation (e.g. Pierre Robin sequence); increase the risk of death or adverse neurodevelopmental outcome (congenital cerebral malformations, chromosomal abnormalities); * Palliative care or treatment limitations because of high risk of impaired outcome.
Where it's running
-
St Luc Louvain
Brussels, Avenaue Hippocrate 10, Belgium Recruiting -
Delta Hospital Brussels
Brussels, Brussels Capital, Belgium Recruiting -
University Hospital Brussels
Jette, Brussels Capital, Belgium Recruiting -
Grand Hospital de Charleroi
Charleroi, Henegouwen, Belgium Recruiting -
Academisch Ziekenhuis Sint-Jan
Bruges, West-Vlaanderen, Belgium Recruiting -
Sint Augustinus Hospital Antwerp
Antwerp, Belgium Recruiting
Show 18 more locations
-
University Hospital Antwerp
Antwerp, Belgium Recruiting -
Chirec-Delta Hospital
Brussels, Belgium Recruiting -
University Hospitals Leuven
Leuven, Belgium Recruiting -
Radboudumc Amalia Children's Hospital Nijmegen
Nijmegen, Gelderland, Netherlands Recruiting -
Maastricht University Medical Center
Maastricht, Limburg, Netherlands Recruiting -
Maxima Medical Center Veldhoven
Veldhoven, North Brabant, Netherlands Recruiting -
Amsterdam University Medical Center
Amsterdam, North Holland, Netherlands Recruiting -
Isala Clinics Zwolle
Zwolle, Overijssel, Netherlands Recruiting -
Leiden University Medical Center
Leiden, South Holland, Netherlands Recruiting -
Erasmus Medical Center - Sophia Children's Hospital
Rotterdam, South Holland, Netherlands Recruiting -
University Medical Center Groningen
Groningen, Netherlands Recruiting -
UMC Utrecht - Wilhelmina Kinderziekenhuis
Utrecht, Netherlands Recruiting -
Clinique Saint-Vincent Liege
Liège, Liege, Belgium Suspended -
Foothills Medical Centre
Calgary, Alberta, Canada Not yet recruiting -
Royal Alexandra Hospital
Edmonton, Alberta, Canada Not yet recruiting -
McMaster Children's Hospital
Hamilton, Ontario, Canada Not yet recruiting -
Montreal Children's Hospital
Montreal, Quebec, Canada Not yet recruiting -
Centre Mère-Enfent Soleil
Québec, Quebec, Canada Not yet recruiting
Study contacts
- Principal investigator: Anne Smits, MD, PhD — Universitair Ziekenhuis Leuven
- Study coordinator: Sinno HP Simons, MD, PhD
- Email: s.simons@erasmusmc.nl
- Phone: +31641376695
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Bedside Spirometry to see if tidal volume matches ideal body weight in non-intubated ARDS
This pilot study tests whether tidal volume measured at bedside with high-flow oxygen and after NIV settings can help classify ARDS patients who are not intubated.
-
Wireless MicroPremVitals Button Sensor for the NICU
This study tests a tiny wireless sensor system to monitor heart rate, oxygen, and temperature in extremely preterm babies in the NICU to see if it works safely without wires.
-
Early breathing therapy just one hour after CABG extubation
This trial tests whether starting respiratory physiotherapy one hour after extubation improves recovery for adults after elective CABG compared with starting on the first postoperative day.
-
Humidification methods in trauma ICU patients on mechanical ventilation
This study tests whether active heated humidifiers or passive heat-and-moisture exchangers work better in trauma ICU patients who need long-term mechanical ventilation.
-
Turkish version of the S3-NIV questionnaire: testing its reliability for home NIV patients
We’re testing whether the Turkish S3-NIV questionnaire reliably measures how well patients on home non-invasive ventilation can manage daily use and comfort.
-
Caffeine in pregnancy: how the mother and baby handle it during delivery
This study tests how caffeine is processed in pregnant people and how much reaches the baby when given shortly before delivery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.